Explosive demand and increased manufacturing capacity for Eli Lilly's weight-loss drug Zepbound drove the company to raise its annual sales forecast by $2 billion on Tuesday, lifting its shares nearly 6%. Lilly said it expects significant production increases in the second half of the year for its obesity treatment and related diabetes drug Mounjaro, for which most doses are in shortage.
Open Flip
HONG KONG: Developer Jinke Property Group has prepared a preliminary plan to restructure debt, it told investors on Tuesday, after becoming the first Chinese-listed developer accepted for re-organisation by a domestic court last week. The company, based in southwestern Chongqing, is among many developers defaulting on debt since the sector slipped into crisis in mid-2021.
Open Flip
One of the great successes of India’s digital transformation has been the establishment of a unified payment interface for B2C transactions. It has brought hitherto-unknown levels of transparency and convenience to the country’s financial system, empowering consumers and businesses with its scale and simplicity. But the task of digitizing payment gateways remained incomplete in the absence.
Open Flip
